Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
Clinical trial NCT04874714 · TERMINATED
Trial details
- NCT number
- NCT04874714
- Sponsor
- Inmunotek S.L.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-30
- Primary completion
- 2023-10-09
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.